Technical Analysis for ATRS - Antares Pharma, Inc.

Grade Last Price % Change Price Change
grade D 3.07 1.66% 0.05
ATRS closed up 1.66 percent on Friday, January 18, 2019, on 43 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Flat
See historical ATRS trend table...

Date Alert Name Type % Chg
Jan 17 Inside Day Range Contraction 1.66%
Jan 16 180 Bearish Setup Bearish Swing Setup 1.99%
Jan 15 Overbought Stochastic Strength 0.00%
Jan 14 Overbought Stochastic Strength 1.66%
Jan 14 Down 3 Days in a Row Weakness 1.66%
Jan 11 Stochastic Sell Signal Bearish -1.29%
Jan 11 Overbought Stochastic Strength -1.29%
Jan 10 Overbought Stochastic Strength -1.92%
Jan 9 50 DMA Resistance Bearish -2.23%
Jan 9 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.23%

Older signals for ATRS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies, and topical gel-based medicines worldwide. The company's products include Tjet/Zomajet, the needle-free auto injectors to deliver human growth hormone treatment to children without the use of a needle; twin-jector EZ II needle free injectors; Medi-Jet auto injectors; Elestrin, an estrogen replacement gel for the treatment of hot flashes; and Gelnique 3%, an oxybutynin gel product for the treatment of overactive bladder. The company is also developing OTREXUP, a product for the delivery of methotrexate using Medi-Jet technology for the treatment of rheumatoid arthritis, poly-articular-course juvenile rheumatoid arthritis, and psoriasis; and VIBEX QS T, an auto injector for the treatment of testosterone deficiency or replacement therapy. In addition, it is developing Vibex auto injectors; disposable pen injectors; and Nestragel, a contraceptive gel. Antares Pharma, Inc. has collaborative and license agreements with Ferring Pharmaceuticals BV; Teva Pharmaceutical Industries, Ltd.; JCR Pharmaceuticals Co., Ltd.; Actavis, Inc.; Daewoong Pharmaceuticals; BioSante Pharmaceuticals, Inc.; Meda Pharmaceuticals; Population Council; and Pfizer Inc. The company was founded in 1979 and is headquartered in Ewing, New Jersey.
Is ATRS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.93
52 Week Low 1.85
Average Volume 1,088,292
200-Day Moving Average 2.9722
50-Day Moving Average 3.1542
20-Day Moving Average 2.9035
10-Day Moving Average 3.077
Average True Range 0.1417
ADX 15.45
+DI 18.4341
-DI 19.1252
Chandelier Exit (Long, 3 ATRs ) 2.7749
Chandelier Exit (Short, 3 ATRs ) 2.9551
Upper Bollinger Band 3.2812
Lower Bollinger Band 2.5258
Percent B (%b) 0.72
BandWidth 26.016876
MACD Line -0.0033
MACD Signal Line -0.035
MACD Histogram 0.0317
Fundamentals Value
Market Cap 480.17 Million
Num Shares 156 Million
EPS -0.12
Price-to-Earnings (P/E) Ratio -25.58
Price-to-Sales 5.48
Price-to-Book 7.21
PEG Ratio -0.24
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.21
Resistance 3 (R3) 3.19 3.14 3.18
Resistance 2 (R2) 3.14 3.10 3.14 3.17
Resistance 1 (R1) 3.10 3.08 3.12 3.12 3.17
Pivot Point 3.05 3.05 3.06 3.05 3.05
Support 1 (S1) 3.01 3.01 3.03 3.03 2.97
Support 2 (S2) 2.96 2.99 2.96 2.97
Support 3 (S3) 2.92 2.96 2.96
Support 4 (S4) 2.94